ZYME FY 2017 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$52M+370.2% YoY

Gross Profit

$11M20.5% margin

Operating Income

-$9M-17.4% margin

Net Income

-$10M-20.1% margin

EPS (Diluted)

$-0.49

Cash Flow

Operating Cash Flow

$219,000

Free Cash Flow

-$3M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$132M

Total Liabilities

$16M

Stockholders' Equity

$116M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$11M	+370.2%
Gross Profit	$11M	-$25M	+143.3%
Operating Income	-$9M	-$38M	+76.2%
Net Income	-$10M	-$34M	+69.2%